Navigation Links
Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
Date:8/13/2009

global/en/home/events/webinar/live/Crystallizatio.html?crel=US_AC_eAdv_PRWebCrystall20090813" onclick="linkClick( this.href );" target="_blank" title="crystal nucleation, growth and dimension">crystal nucleation, growth and dimension can be maintained on scale. This approach highlights the necessity for a link to be forged between crystal size, form, kinetics, etc. and the attained mixed environment. In turn, a platform is produced to facilitate the right first time crystallization scale-up, tech transfers and scale-down assessments of this hydrodynamically limited process.

The webinar presenter, Mark Barrett, received his Ph.D. from University College Dublin (UCD) in Ireland, where he also studied Chemical Engineering. His thesis work focused on crystallization development and scale-up. Previously, Mark worked for Schering-Plough as a Process Development Engineer. Mark is now a Senior Research and Development Engineer at the Solid State Pharmaceutical Cluster (SSPC), based in Ireland.

###

Read the full story at http://www.prweb.com/releases/crystallization/PAT/prweb2740064.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Seambiotic USA and NASA Glenn Research Center Signed Agreement for Large Scale Microalgae Process Optimization
2. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
3. ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry
4. U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
5. Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
6. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
7. ThalesNano Flow Reactor Realizes Microwave Speed With Scale-up Ability
8. DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
9. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
10. Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
11. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process: From Lab to Plant
(Date:12/15/2009)... Department of Energy (DOE) bio-energy research centers, has selected ... intellectual property. , ... ... Surety, LLC , the leading provider of data ... BioEnergy Institute (JBEI), one of three Department of Energy ...
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, The Future ... to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The ... Future of Orphan Diseases Therapeutics - Market ...
(Date:12/15/2009)... Microscopy (AFM) have been developed and are opening up a ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface ... all in a single force distance curve. , ... ... diameter NeedleProbes are enabling unique measurements at the ...
(Date:12/15/2009)... Dec. 15 The Center for ... Communications, is pleased to announce the full ... Accounting and Reporting Congress . The forum ... on March 16-17, 2010. ,, Over 1,500 ... have attended this premier event since its ...
Breaking Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
... Key milestones, - Strong R&D investments, especially in EHT Dx21 and ... - Recruitment of 311 samples achieved for EHT Dx21, ... - Expansion of the strategic collaboration with Allergan and extension, ... Appointment of a new Management Board, - New positioning of Genomic ...
... March 3 NeoGenomics, Inc. (OTC Bulletin Board: ... its fourth quarter and full year 2008 financial results on ... conference call to discuss their Q4 and full year 2008 ... Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 ...
... Leverage Respective Technology and Market Experience to Support ... Sparta Systems, Inc., the leading provider of ... the appointment of two software and life sciences ... Diane Carlson, vice president of marketing communications, and ...
Other Biology Technology:ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 2ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 3ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 4ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 5ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 6ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 7ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 8ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 9ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 10ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 11NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009 2Sparta Systems Bolsters Executive Leadership Team with Strategic Additions 2Sparta Systems Bolsters Executive Leadership Team with Strategic Additions 3
(Date:12/15/2009)... WI, December 15, 2009 Economics, environmental impacts, ... factors that influence the overall success of an ... on the system, forcing individuals and social groups ... order to survive. , Experiential learning theory ... result of firsthand experiences. Such lessons are especially ...
(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...
(Date:12/15/2009)... HERNDON, Va., Dec. 15 The PTR Group, ... today announced that it has agreed to sponsor three ... US FIRST Robotics Competition ( http://usfirst.org ). ... high school teams in three different states. The ... in Rockwall, TX, and James Madison HS in Vienna, ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 13440 1ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 13440 2LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 1LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 2Matrixx Initiatives Inc Sets Time for Discussion of First Quarter Fiscal 2010 Financial Results 53918 1Matrixx Initiatives Inc Sets Time for Discussion of First Quarter Fiscal 2010 Financial Results 53918 2
... in the body, a virus such as HIV invades body ... membrane. Once inside the cell, the invading microbe's genetic material ... produce more copies of the virus, which then spill out ... assumed that once a virus begins fusing with a cell's ...
... in the impact of malaria is in prospect with a ... next year. Success in the trial would open the way ... debilitating and often fatal disease - over 500,000,000 people. ... is collaborating with the Papua New Guinea Institute of Medical ...
... San Francisco VA Medical Center (SFVAMC) and the University ... associated with lymphocytic bronchitis, which is thought to lead ... long-term failure of transplanted lungs. , The researchers hope ... and more accurate standard test for chronic lung rejection, ...
Other Biology News:Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 2Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 3Old drug, new tricks: Prospects for slashing the impact of malaria 2Researchers identify genes associated with lung transplant rejection 2
... Safe photographic filter (S37100, Photographic Filters ... is ideal for black-and-white photography of ... DNA gel stain, the safer ethidium ... Safe photographic filter is identical to ...
The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
LAL Chromogenic Endpoint assay...
Biology Products: